Skip to main content

Table 1 Baseline characteristics of Pre eMeds and Post eMeds cohorts

From: “Antibiotic hardstop” on electronic prescribing: impact on antimicrobial stewardship initiatives in patients with community acquired pneumonia (CAP) and infective exacerbations of chronic obstructive pulmonary disease (IECOPD)

 

Pre eMeds

Post eMeds

p-value

Total patients

100

100

 

Age in years, median (IQR)

74.5 (62–84)

77 (67–87)

0.1718

RACF

18

30

0.0469*

Bacteraemia

3

5

0.4705

CKD

10

19

0.0707

T2DM

17

28

0.0625

Respiratory disease

55

53

0.7766

PVD

2

5

0.2484

Immunosuppressed

7

13

0.1573

Haematological Malignancy

5

5

1.0000

ICU admission

20

10

0.0477*

Directed therapy

19

12

0.1714

ID involvement

21

14

0.1927

CURB65 mean (SD)

2.98 (1.21)

3.02 (1.18)

0.814

CURB65 categorised (%)

 0–1

12

10

0.6513

 2

23

19

0.4874

 ≥ 3

65

71

0.3631

  1. P-value calculated using two-sample test of proportions for categorical variables and two-sample t-test for continuous variables
  2. Abbreviations: SD, standard deviation; CKD, chronic kidney disease; T2DM, type 2 diabetes mellitus; PVD, peripheral vascular disease; ICU, intensive care unit; ID, infectious diseases, RACF, Residential Aged Care Facility
  3. *statistically significant p-value (p ≤ 0.05)
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us